The standardization of cardiac life support protocols, the establishment of rapid response emergency medical systems, and the education and certification of both medical and lay personnel have reduced the mortality associated with sudden cardiac arrest; however, mortality rates in most areas are still approximately 85%.2 Cardiac arrest protocols include the initial establishment of a venous access to facilitate drug administration. The patency of this access is maintained with a continuous infusion of fluids which routinely contain 5% dextrose. When an individual is found unconscious and no history is available, an ampule of 50% dextrose is frequently administered to correct for possible hypoglycemia. These uses of dextrose are generally considered either beneficial or at least innocuous. The treatment groups in this study were specifically designed to evaluate the use of dextrose in an experimental model mimicking the clinical setting of cardiac arrest. Several experimentaY* and clinica19x10 studies have demonstrated that hyperglycemia prior to primary cerebral ischemic events will increase mortality and the severity of the associated neurologic deficit. The potential clinical importance of postresuscitation blood glucose levels was recently suggested in a retrospective study of resuscitated patients." Elevated blood glucose levels at the time of hospital admission were strongly correlated with an adverse neurologic outcome. However, the role of exogenous dextrose administration in elevating blood glucose levels and exacerbating ischemic damage was not evaluated by these investigators.
We recently demonstrated that 5% dextrose administered prior to cardiac arrest and resuscitation increases the anticipated mortality and neurologic deficit." However, in the vast majority of cardiac arrest cases, dextrose administration begins during, rather than prior to, the resuscitation effort. In this study we tested the hypothesis that even the routine administration of dextrose solutions begun at the initiation of the resuscitation effort impairs survival following resuscitation from cardiac arrest.
MATERIALS AND METHODS

Animal Preparation and Experimental Procedure
Thirty-one fed mongrel dogs (15.9 to 28.6 kg) were premeditated with morphine sulfate, (1.5 mg/kg IM). Anesthesia was induced with 5% halothane via mask and demand ventilation.
Once The volume of each bolus (11 to 21 mL of solution) was adjusted to the dog's body weight to give a volume corresponding to a dose of one 50-mL ampule of 50% dextrose to a 70-kg man. Total fluid volumes and total dextrose for each group is given in Table 1. At one, two, six, and 24 hours postarrest, a neurologic score'* described in Dogs were randomly assigned to either dextrose containing (D5LR) or dextrose free (LR) infusion groups. Each infusion group contained a subgroup of five dogs given an initial dextrose bolus, thus defining four treatments which varied only by total dextrose to be administered. ate neurologic scores. Fisher's exact test was used for survival data. All average data is expressed as mean + 1 SEM. The sample size (n) for all experiments is the number of animals. Exact P values are given except when P is greater than .OS where it is reported as nonsignificant (NS).
RESULTS
The average values of the two infusion treatment groups for the prearrest variables of opera-LUNDY ET AL tive time (anesthesia induction to fibrillation), heart rate, arterial blood pH, end-expiratory carbon dioxide, and arterial blood glucose were not found to be statistically different (Table 3) . Body weight and mean arterial pressure were statistically higher in the group that was to be given 5% dextrose in lactate Ringer's despite random assignment of animals to treatment groups. The subgroups receiving the additional bolus injection of 50% dextrose were not found to be statistically different in the prearrest, resuscitation, or primary postarrest variables for cardiovascular and respiratory function, survival time and neurologic deficit scores but tended to have a lower blood pH. The bolus subgroups were thus included in the two infusion treatment groups for subsequent analysis.
All 31 dogs were successfully resuscitated. Figure 1 illustrates the time of death for each dog and the survival rate for each group. All 13 dogs that received lactated Ringer's infusions were alive at 24 hours. Ten of 18 dogs (56%) receiving dextrose infusion were dead at 24 hours, and as early as 11 hours postresuscitation 9 of these 10 dogs had died. Mortality was both early and excessive in dogs receiving the dextrose infusion.
None of the dogs died from ventricular fibrillation and all dogs had regained spontaneous ventilation with hyperpnea within less than two hours. All the animals that died had fixed and dilated pupils, little or no somatosensory response, and death was often preceded by convulsivelike activity, limb extension with arching of the back. Cardiopulmonary depresssion appeared secondary to progressive neurologic damage. Subsequent postmortem examination failed to reveal any iatrogenic problems related to the thoracotomy or resuscitation that could account for the death of any animal.
There was no statistical difference detected in prearrest blood glucose concentrations (Table 3) . Both groups had increased postarrest blood glucose levels (Table 4) ; however the dogs receiving the dextrose infusion had significantly higher postresuscitation glucose levels. The exogenously administered dextrose presumably added to that mobilized by the animal in response to stress. The time from the beginning of resuscitation to the establishment of stable cardiac rhythm and a mean arterial blood pressure greater than 75 mm Hg without external compression (resuscitation time) was not statistically different between groups (Table 5) . Also, no difference was detected between the number of defibrillating shocks, amount of lidocaine, NaHCO,, or morphine used. The time the animals required ventilatory assistance was not different at a P = .05 level despite an almost doubling of ventila.tion time in the group of dogs that received the dextrose infusion. There was no detectable difference in the interval from arrest until the animals could be extubated; however, all animals receiving an infusion of lactated Ringer's were extubated by three hours. In contrast, four of the 18 dogs receiving DSLR infusion died while still intubated.
A marked difference in epinephrine requirements was observed for the dextrose infusion group (Table 5) . This group required, on the average, approximately three times more (P = .05) epinephrine administered as injections than the lactated Ringer's infusion group. Also, the length of time the dextrose infusion animals required an epinephrine infusion to maintain 100 to 125 mm Hg mean arterial blood pressure was almost twice as long as that of the group without dextrose, but this difference did not reach statistical significance. (The time of infusion is reported because the epinephrine infusion rate was continually titrated to maintain a mean arterial pressure of 100 to 125 mm Hg). At six hours, the only animals requiring epinephrine infusion were in the dextrose infusion group (all having received a dextrose bolus) and the average infusion rate at this time for the four animals was 2.6 pg/kg/ min, or more than half the initial infusion rate used to initiate resuscitation. Figure 2 indicates the mean arterial pressure from the end of the six-hour support period to 24 hours, during which time no statistically significant differences in mean arterial pressure were detected. Heart rate at six hours was not statistically different but at 25 hours it was higher in the group without dextrose (Table 4) . Urine was collected for the one to two hours prior to and, when possible, for six hours after the arrest. No more than 850 mL of urine was collected during this eight hours despite the infusion or injection of approximately 800 mL of fluid. Thus, there was no suggestion of a glucose induced diuresis, hypotension, or reflex tachycardia. the sample size in the dextrose infusion group is reduced to 13 (5 of 18 dead) by six hours and to 8 (10 of 18 dead) by 24 hours reducing the statistical separation of these groups. This analysis clearly biases the data in favor of the dextrose group in that the dextrose group thus contains only the least impaired dogs while the no dextrose group retains all animals. Despite the bias The total neurologic deficit score (Table 2) at one, two, six, and 24 hours is illustrated in Fig 3. As early as one hour postarrest the dextrose infusion group had a significantly greater neurologic deficit score than the lactated Ringer's group (Student's t). This separation is retained at two, six, and 24 hours. If dead animals (score of 100) are excluded from such analysis (Fig 4) introduced by this form of analysis the greater neurologic deficit in the group receiving dextrose is still apparent. In each group the motor component of the neurologic score contributed strongly to the total deficit (Fig 5) . The respiratory, spinal nerve, and cranial nerve indices of neurologic deficit were less discriminating. They often failed to show deficits at 24 hours, and the spinal and cranial nerve performance was often near normal within the first six hours postarrest. When the motor deficit score was plotted relative to change in blood glucose concentration (postresuscitation/ prearrest), a neurologic deficit threshold was apparent as blood glucose values increased twofold (Fig 6) .
DISCUSSION
The idea that glucose is damaging during cerebral ischemic events is not entirely new, but it is substantially underappreciated in both experimental protocols and daily clinical practice. Several studies have been published indicating that hyperglycemia prior to a focal or global cerebral insult increases neurologic damage. the most directly relevant to the clinical setting. However, there have been some important criticisms of studies using such models.13 One major problem is the high failure rate associated with many closed chest, external compression resuscitation attempts in dogs. In one such study involving 12 minutes of cardiac arrest, only 13 of 34 dogs were successfully resuscitated.14 Such low resuscitation rates raise concerns about the unusual tolerance of the small subgroup of surviving animals. The reasons for low resuscitation rates are rarely defined, but this failure to resuscitate is certainly due, in part, to variable and inadequate cerebral blood flow associated with closed chest compressions" which may lengthen the effective period of ischemia. These concerns make comparisons of data within and between such studies difficult at best.
To obviate these problems, we chose to use open chest, direct cardiac compression to maintain a mean arterial pressure greater than 75 mm Hg and to hold our circulatory arrest time to a controlled six minutes. Resuscitation attempts that use direct cardiac compression result in improved cerebral blood flo~,'~,'~ better maintenance of brain electrical activity," and improved brain recovery.19,20 Of the last 86 dogs fibrillated for this and two other studies,12v2' we resuscitated 85, a failure rate of approximately 1.2%. These results suggest that more reliable and consistent data can be obtained in canine models of cardiac arrest and resuscitation when direct cardiac compression is used as an alternative to closed chest compression. It is important to note that we are not necessarily advocating direct cardiac compression as the preferred technique in the clinical setting because this approach has not been fully evaluated in a controlled study.
Previous studies have reported that in canine and feline models, arrest times from 12 to 16 minutes were required to consistently produce detectable neurologic deficits.'4S22-26 This is in contrast to humans who often develop neurologic damage after as little as four to six minutes of global cerebral ischemia.15,27 This apparent discrepancy has caused the questioning of the clinical relevance of previous cardiac arrest studies. Many causes can be suggested for the relatively long arrest times required to produce damage in animal studies, such as cortical mass differences, cooling effects in the laboratory setting, and species differences. Our data indicate that the reported differences may, in part, be due to the detrimental effects of dextrose. Dextrose is frequently administered to humans in a clinical setting, but it is not consistently used in a laboratory setting. We elected to begin resuscitation after only six minutes of cardiac arrest to more closely mimic clinically relevant arrest/resuscitation times and to use dextrose-containing intravenous fluids as they are used clinically.
Another potential criticism of using cardiac arrest and resuscitation as a model of global cerebral ischemia is the concern over the use of multiple drugs and their interactions with each other and anesthetics. Although we could not completely eliminate this influence, we did reduce and control its impact. The drugs used during the resuscitation effort were the minimum doses and types required to maintain blood pressure and cardiac function. We chose halothane as our general anesthetic because it permits rapid induction and recovery and it has not been reported to have protective effects following cerebral ischemia, as reported for example in the use of barbiturate anesthesia.28 The level of anesthesia for each animal was reduced and standardized by inducing arrest after the cornea1 lid reflex had consistently returned.
Ventilatory and blood pressure support was restricted to six hours and the level of support provided was recorded as an experimental variable. We chose to stop support at six hours to minimize and standardize the support given each animal. The fact that dogs receiving dextrose infusion required more pharmacologic support is interpreted as a detrimental effect of dextrose infusion. One might argue that continued blood pressure support would have "saved" the dogs that died after six hours. This might be true but would not change the conclusion that dogs given dextrose during resuscitation have greater morbidity and higher mortality than those given an infusion free of dextrose. Continuing intensive cardiorespiratory support for the full six hours favored the survival of the dextrose infusion group. Despite this more intensive support, the dextrose infusion group had the greater mortality.
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evaluations, complete objectivity is difficult to obtain. The neurologic evaluation used in this study is our modification'* of a neurologic assessment developed by Nemoto et alz3 and used by others in similar protocols.24 In order to minimize potential bias, at least two investigators performed every neurologic examination. For any result which was unclear, written descriptions of the various conditions were consulted and the examination was repeated until a score was agreed upon. Table 2 gives the contribution of each scored deficit.
In this study the motor deficit component contributed most to the overall neurologic deficit score (Fig 5) , perhaps due to the greater vulnerability of these functions compared to those controlled by the brain stem or spinal cord.3 Our functional assessments are consistent with histologic studies of brain tissue following arrest and resuscitation. These studies characteristically show damage in the cortex, basal ganglia, and cerebellum with relative sparing of the brain stem.3.29-37 Although morphine was used to alleviate postoperative pain, no animal required morphine for more than 12 hours postarrest, and there was no difference detected between groups in the amount of morphine used. This permitted the 24-hour neurologic deficit score to be relatively free from the influence of anesthesia, analgesia, or sedation.
Potential concern might arise regarding assigning a neurologic deficit score of 100 points to a dead dog. This could be misleading if the cause of death were ventricular fibrillation, hemorrhage, or any other noncerebral cause. Although we cannot absolutely exclude the possibility that the deaths were unrelated to the neurologic impairment, the pattern of death for the ten dogs (10 of 31 tested) that died in this study before 24 hours was clearly suggestive of a primary cerebral event. Maximum deficit in cranial and spinal nerves was recorded prior to progessive depression of cardiopulmonary function. The typical pattern was one of fixed and dilated pupils with limb extension and arching of the back suggestive of brain swelling. This pattern and the absence of any evidence of primary cardiopulmonary failure justify the inclusion of dead dogs (scored as a maximum neurologic deficit of 100) in the analysis of data as shown in Fig 3. Figure 4 shows the neurologic deficit data including only live dogs. Regardless of the type of statistical analysis the conclusion remains the same.
Glucose and Ischemic Damage
Since most cardiac arrests occur out of the hospital, prior administration of dextrose and the potential for a damaging role of elevated blood glucose in the outcome of resuscitated patients has not been a major clinical concern. Furthermore, Pulsinelli7 has reported that the postreperfusion administration of glucose in a four-vessel occlusion model of cerebral ischemia in the rat had no obvious neurologic consequences. However, a recent study by Longstreth and Inui" reported that postresuscitation blood glucose levels taken at hospital admission were strongly correlated with neurologic outcome. They reported that patients who did not awaken after resuscitation had a mean blood glucose level of 341 mg/dL, a value not uncommon in a clinical setting. The admitting blood glucose concentration of those that awoke (262 mg/dL) and the subgroup that was without neurologic deficit (251 mg/dL) was significantly lower. They did not speculate on the possibility that dex.trose administration may have contributed to the greater neurologic damage they observed in patients with higher blood glucose. Our study specifically focused on the evaluation of dextrose administration begun after the insult of cardiac arrest to mimic a typical out-of-hospital arrest and resuscitation sequence. Administration of intravenous dextrose-containing fluids would contribute to the elevation of blood glucose which, particularly in low flow states, could increase glycolytic flux and potentially increase neurologic deficit.
In a previous study" we confirmed the observations of Pulsinelli et al7 and Meyers and Yamaguchi3 that pretreatment with glucose was detrimental. The current results indicate that dextrose administered after, as well as before, the initiation of cerebral ischemia can be damaging. Pulsinelli's7 observation that postreperfusion administration of glucose is of no consequence is perhaps due to species differences, or possibly differences in the model, ie, partial cerebral ischemia may occur in the four vessel occlusion model whereas total ischemia is assured during cardiac arrest. The duration and severity of the ischemic period, the rate at which reperfusion occurs and the existence and duration of reactive hyperemia or persistent low flow states may also contribute to differences in the response of these models of cerebral ischemia. Another possible explanation is the different method used for dextrose administration. Pulsinelli gave rats an intraperitoneal injection of D-glucose after reperfusion, whereas we tested intravenous administration of both a bolus and a continuous 24-hour infusion of dextrose. The dextrose bolus alone was minimally damaging and the 24 hour dextrose infusion was found to be damaging with or without the bolus of dextrose.
Dextrose administration in the setting of experimental cardiac arrest and resuscitation is associated with greater neurologic deficit and mortality. In an attempt to refine this relationship, blood glucose levels and neurologic deficit were plotted using the postresuscitation blood glucose values and the motor deficit score. No strong correlation was found with the absolute values of blood glucose. However, when we plotted the relative change in blood glucose against motor deficit, we noted a threshold for damage at the point where blood glucose is increased approximately twofold (Fig 6) . Others38-40 have reported a threshold effect when evaluating the role of tissue lactate in ischemic brain damage.
During normal blood flow and oxygen tension, brain tissue lactate has been reported to be approximately 1.5 mmol/L/kg.41
This steadystate concentration could be maintained by a small, yet constant glycolytic metabolism and a constant flow of blood to remove lactate. Should blood flow (and hence 0, and glucose delivery change), it is conceivable that the balance between production and removal of lactate shifts such that tissue lactate increases. Cerebral blood flow 15 to 30 minutes after resuscitation following total global ischemia has been reported to be less than 20% of the original value.zs~42-48 This hypoperfusion phenomenon can last more than 18 hours postresuscitation.
Meyers3* and others39,40 have shown a threshold for damage exists when tissue lactate exceeds 16 to 20 mmol/L/kg. Presumably, this threshold can be reached when a marked reduction in cerebral blood flow is combined with an increase in blood glucose, a situation that will drive glycolytic flux and result in the production and accumulation of tissue lactate. Interestingly, Pulsinelli et al have shown in the four-vessel occlusion model of global cerebral ischemia and reperfusion in the rat,' that with an increase in blood glucose slightly more than twofold, histologic damage was detected in areas of the brain where blood flow was reduced to 15%, but no damage was detected where blood flow was reduced to 25%. Our analysis of a rather abrupt transition, or threshold, for cerebral damage is consistent with this regional blood how analysis. We, however, draw attention to metabolic substrate delivery as a determining factor and not blood flow changes alone. In a state of prolonged ischemia, the addition of supplemental glucose to the blood, through an intravenous infusion, would increase tissue lactate production and accumulation, which could cause progressive tissue damage. In a recent study from our laboratory,49 2-deoxyglucose was used to inhibit glycolytic metabolism in the setting of hyperglycemia-aggravated ischemic damage. In the Wistar rat, severe forebrain ischemia, but no mortality, is produced by permanent occlusion of the vertebral arteries and 20 minutes of occlusion of the carotid arteries. The addition of 3 g/kg glucose to the four-vessel occlusion model of cerebral ischemia produced 100% mortality in 24 hours; however, the further addition of 1.6 g/kg 2-deoxyglucose reduced the mortality to 40% and reduced morbidity. We concluded that augmented ischemic damage during hyperglycemia is a consequence of glycolytic flux because 2-deoxyglucose, which decreases glucose uptake and glycolytic flux, decreased mortality and morbidity. The infusion of 5% dextrose in the present study parallels the hyperglycemia in the rat study; however, it remains speculative whether a comparable inhibition of glycolytic metabolism would eliminate the augmented damage we observed in resuscitated dogs. Thus, we can only hypothesize that the mechanism of augmented damage is through glycolytic metabolism to lactate. Hyperglycemia alone does not cause the damage, and the mechanisms of ischemic damage are manifold and beyond the scope of this study.
Although the heart metabolizes lactate more readily than the brain, lactate accumulation in the myocardium is ultimately associated with depressed pump function.50 If hyperglycemia exacerbates myocardial lactate accumulation, then an additional component of the epinephrine dependency may have been the need for inotropic support of a failing heart. Thus, although we believe the brain is the primary site of hyperglycemia-aggravated ischemic damage, we cannot exclude-and in fact would hypothesize-myocardial, renal, or other tissue damage as contributors to overall morbidity and mortality.
This study utilized a standardized and highly reproducible model of cardiac arrest and resuscitation. The only experimental variable was the administration of clinically relevant doses of dextrose as an intravenous drip and/or bolus. While no specific mechanism was evaluated, this descriptive study indicates that dextrose administration during and after resuscitation from cardiac arrest is associated with a greatly increased mortality and neurologic morbidity. Further, while all dogs were successfully resuscitated, those receiving dextrose infusions required substantially greater cardiorespiratory support in 13 the postarrest period. These data suggest that in the halothane-anesthetized dog postarrest administration of dextrose may elevate the blood glucose concentration enough to increase mortality and morbidity. With the accumulation of evidence supporting the injurious role of elevated blood glucose concentration during ischemic events, we propose that dextrose-containing intravenous fluids may impair recovery from cardiac arrest and thus should be avoided in this setting. 
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